Chemical ID |
Chemical Name |
Interaction |
Interaction Action |
Publication |
---|
C404910 |
2,2-bis(4-hydroxyphenyl)-1,1,1-trichloroethane |
2,2-bis(4-hydroxyphenyl)-1,1,1-trichloroethane affects the expression of HIVEP1 mRNA | affects expression | 19414516
|
C016403 |
2,4-dinitrotoluene |
2,4-dinitrotoluene affects the expression of HIVEP1 mRNA | affects expression | 21346803
|
C009505 |
4,4'-diaminodiphenylmethane |
4,4'-diaminodiphenylmethane results in increased expression of HIVEP1 mRNA | increases expression | 18648102
|
D000643 |
Ammonium Chloride |
Ammonium Chloride results in increased expression of HIVEP1 mRNA | increases expression | 12420312
|
D017638 |
Asbestos, Crocidolite |
Asbestos, Crocidolite results in increased expression of HIVEP1 mRNA | increases expression | 18687144
|
D015123 |
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide |
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of HIVEP1 mRNA | decreases expression | 19150397
|
C006780 |
bisphenol A |
bisphenol A results in increased expression of HIVEP1 mRNA | increases expression | 19371625
|
D020122 |
tert-Butylhydroperoxide |
tert-Butylhydroperoxide results in decreased expression of HIVEP1 mRNA | decreases expression | 15003993
|
D015025 |
Zearalenone |
Zearalenone results in increased expression of HIVEP1 mRNA | increases expression | 19371625
|
D019833 |
Genistein |
Genistein results in increased expression of HIVEP1 mRNA | increases expression | 19371625
|
C029938 |
nickel sulfate |
nickel sulfate results in increased expression of HIVEP1 mRNA | increases expression | 16780908
|
C016340 |
o,p'-DDT |
o,p'-DDT results in increased expression of HIVEP1 mRNA | increases expression | 19371625
|
C081489 |
valsartan |
valsartan inhibits the reaction [AGT protein results in increased expression of HIVEP1 mRNA] | decreases reaction|increases expression | 19225232
|
Disease ID |
Disease Name |
Direct Evidence |
Inference Chemical Name |
Inference Score |
Publication |
---|
MESH:D000138 |
Acidosis |
|
Ammonium Chloride |
3.68 | 18287403 |
MESH:D055371 |
Acute Lung Injury |
|
nickel sulfate |
4.39 | 11954676 16100012 19131640 12718980 |
MESH:D000230 |
Adenocarcinoma |
|
Genistein |
2.50 | 11473722 |
MESH:D000236 |
Adenoma |
|
4,4'-diaminodiphenylmethane |
2.80 | 3712494 |
MESH:D001660 |
Biliary Tract Diseases |
|
4,4'-diaminodiphenylmethane |
5.15 | 1440618 11289319 |
MESH:D001862 |
Bone Resorption |
|
bisphenol A |
3.94 | 11985600 |
MESH:D001943 |
Breast Neoplasms |
|
bisphenol A |
2.35 | 17123778 |
MESH:D001943 |
Breast Neoplasms |
|
Genistein |
2.35 | 17200150 16873071 16541309 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
2,4-dinitrotoluene |
4.68 | 16705839 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
4,4'-diaminodiphenylmethane |
4.68 | 3581430 7296757 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Genistein |
4.68 | 16924424 |
MESH:D002278 |
Carcinoma in Situ |
|
bisphenol A |
5.11 | 17123778 |
MESH:D002292 |
Carcinoma, Renal Cell |
|
4,4'-diaminodiphenylmethane |
2.71 | 7296757 |
MESH:D006332 |
Cardiomegaly |
|
valsartan |
4.22 | 19597038 |
MESH:D009202 |
Cardiomyopathies |
|
valsartan |
4.49 | 16247790 |
MESH:D002318 |
Cardiovascular Diseases |
|
Genistein |
8.00 | 16332659 |
MESH:D002318 |
Cardiovascular Diseases |
|
valsartan |
8.00 | 11230374 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
4,4'-diaminodiphenylmethane |
6.83 | 7505956 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide |
6.83 | 20889678 |
MESH:D002779 |
Cholestasis |
|
4,4'-diaminodiphenylmethane |
3.21 | 9022650 19486331 |
MESH:D003110 |
Colonic Neoplasms |
|
Genistein |
2.30 | 17182828 |
MESH:D003324 |
Coronary Artery Disease |
|
valsartan |
3.92 | 17719468 |
MESH:D003384 |
Coxsackievirus Infections |
|
valsartan |
5.96 | 20392896 |
MESH:D003490 |
Cyanosis |
|
2,4-dinitrotoluene |
4.12 | 18551238 |
MESH:D017449 |
Dermatitis, Allergic Contact |
|
4,4'-diaminodiphenylmethane |
7.49 | 8970840 18759878 14531868 8156756 11298694 12868966 2524372 11906362 |
MESH:D017449 |
Dermatitis, Allergic Contact |
|
nickel sulfate |
7.49 | 16780908 16823706 11298694 |
MESH:D003877 |
Dermatitis, Contact |
|
4,4'-diaminodiphenylmethane |
3.58 | 3621924 2952479 |
MESH:D003921 |
Diabetes Mellitus, Experimental |
|
valsartan |
4.66 | 11508273 |
MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
Genistein |
2.50 | 16647724 |
MESH:D003928 |
Diabetic Nephropathies |
|
valsartan |
4.86 | 11427623 18630688 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
2,4-dinitrotoluene |
3.92 | 21346803 18551238 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
4,4'-diaminodiphenylmethane |
3.92 | 18648102 9022650 8291058 6679447 7440962 9653073 18289764 11289319 18692083 6482804 9328219 16192314 1440618 |
MESH:D004714 |
Endometrial Hyperplasia |
|
Genistein |
4.71 | 16402032 |
MESH:D016889 |
Endometrial Neoplasms |
|
Genistein |
3.41 | 11473722 |
MESH:D004938 |
Esophageal Neoplasms |
|
4,4'-diaminodiphenylmethane |
4.45 | 3581430 |
MESH:D004938 |
Esophageal Neoplasms |
|
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide |
4.45 | 20426865 |
MESH:D005350 |
Fibroma |
|
4,4'-diaminodiphenylmethane |
5.15 | 6705139 |
MESH:D005355 |
Fibrosis |
|
valsartan |
4.87 | 16893502 |
MESH:D005909 |
Glioblastoma |
|
Genistein |
3.31 | 16598420 |
MESH:D015432 |
Glomerulonephritis, Membranoproliferative |
|
valsartan |
5.64 | 16928621 |
MESH:D006042 |
Goiter |
|
4,4'-diaminodiphenylmethane |
4.12 | 7505956 |
MESH:D006333 |
Heart Failure |
|
valsartan |
4.30 | 19027736 |
MESH:D006505 |
Hepatitis |
|
4,4'-diaminodiphenylmethane |
3.61 | 6705139 |
MESH:D006965 |
Hyperplasia |
|
4,4'-diaminodiphenylmethane |
4.04 | 15034207 |
MESH:D006973 |
Hypertension |
|
valsartan |
3.75 | 18344623 11427623 20102058 12692753 16475468 12850387 10903974 18390891 |
MESH:D006974 |
Hypertension, Malignant |
|
valsartan |
6.54 | 11560862 |
MESH:D007333 |
Insulin Resistance |
|
bisphenol A |
3.34 | 16393666 |
MESH:D007565 |
Jaundice |
|
4,4'-diaminodiphenylmethane |
5.15 | 9022650 8074119 |
MESH:D007674 |
Kidney Diseases |
|
valsartan |
4.00 | 10903974 12164870 16893502 |
MESH:D007680 |
Kidney Neoplasms |
|
2,4-dinitrotoluene |
7.58 | 16705839 |
MESH:D007680 |
Kidney Neoplasms |
|
4,4'-diaminodiphenylmethane |
7.58 | 6582329 |
MESH:D007938 |
Leukemia |
|
Genistein |
3.06 | 17468513 18980019 |
MESH:D008105 |
Liver Cirrhosis, Biliary |
|
4,4'-diaminodiphenylmethane |
3.24 | 15034207 9327722 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Genistein |
3.09 | 17823541 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
valsartan |
3.09 | 16872305 15619341 15504291 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
4,4'-diaminodiphenylmethane |
2.58 | 598648 3712494 1399818 6587162 |
MESH:D055370 |
Lung Injury |
|
Asbestos, Crocidolite |
4.13 | 17365036 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Genistein |
2.99 | 12929590 14578162 |
MESH:D008654 |
Mesothelioma |
|
Asbestos, Crocidolite |
3.21 | 18303189 16966607 16166281 |
MESH:D009203 |
Myocardial Infarction |
|
Genistein |
2.89 | 17141266 |
MESH:D015428 |
Myocardial Reperfusion Injury |
|
Genistein |
3.72 | 17141266 |
MESH:D009336 |
Necrosis |
|
2,4-dinitrotoluene |
3.97 | 18551238 |
MESH:D009362 |
Neoplasm Metastasis |
|
4,4'-diaminodiphenylmethane |
2.50 | 3581430 |
MESH:D009421 |
Nervous System Malformations |
|
bisphenol A |
10.20 | 11399458 16427766 |
MESH:D009421 |
Nervous System Malformations |
|
Genistein |
10.20 | 16427766 |
MESH:D009436 |
Neural Tube Defects |
|
4,4'-diaminodiphenylmethane |
2.96 | 6679447 |
MESH:D009784 |
Occupational Diseases |
|
2,4-dinitrotoluene |
9.14 | 12819281 16049721 |
MESH:D009784 |
Occupational Diseases |
|
4,4'-diaminodiphenylmethane |
9.14 | 4026338 6482804 |
MESH:D009902 |
Optic Neuritis |
|
4,4'-diaminodiphenylmethane |
5.15 | 3988306 |
MESH:D010024 |
Osteoporosis |
|
Genistein |
3.30 | 19401787 |
MESH:D015663 |
Osteoporosis, Postmenopausal |
|
Genistein |
4.17 | 16169203 |
MESH:D010049 |
Ovarian Diseases |
|
bisphenol A |
5.11 | 11985600 |
MESH:D010051 |
Ovarian Neoplasms |
|
Genistein |
2.62 | 19005980 |
MESH:D010212 |
Papilloma |
|
4,4'-diaminodiphenylmethane |
3.59 | 7296757 |
MESH:D010787 |
Photosensitivity Disorders |
|
4,4'-diaminodiphenylmethane |
4.60 | 6228378 |
MESH:D010995 |
Pleural Diseases |
|
Asbestos, Crocidolite |
5.00 | 10923243 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
bisphenol A |
4.07 | 10548101 |
MESH:D019048 |
Prostatic Intraepithelial Neoplasia |
|
bisphenol A |
4.29 | 20887781 |
MESH:D011471 |
Prostatic Neoplasms |
|
bisphenol A |
3.39 | 16740699 |
MESH:D011471 |
Prostatic Neoplasms |
|
Genistein |
3.39 | 15256057 16925846 15378649 |
MESH:D011507 |
Proteinuria |
|
valsartan |
4.94 | 17664856 18344623 12164870 |
MESH:D011629 |
Puberty, Precocious |
|
bisphenol A |
4.90 | 10548101 |
MESH:D011658 |
Pulmonary Fibrosis |
|
Asbestos, Crocidolite |
6.33 | 17322281 17365031 15814490 17975199 |
MESH:D011658 |
Pulmonary Fibrosis |
|
valsartan |
6.33 | 17241526 |
MESH:D012162 |
Retinal Degeneration |
|
4,4'-diaminodiphenylmethane |
3.43 | 3692021 |
MESH:D012640 |
Seizures |
|
2,4-dinitrotoluene |
2.58 | 18551238 |
MESH:D012878 |
Skin Neoplasms |
|
tert-Butylhydroperoxide |
2.72 | 8532709 |
MESH:D019966 |
Substance-Related Disorders |
|
bisphenol A |
4.10 | 16684133 16045194 |
MESH:D013964 |
Thyroid Neoplasms |
|
4,4'-diaminodiphenylmethane |
2.95 | 6582329 1399818 6587162 3712494 7505956 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
2,4-dinitrotoluene |
5.10 | 16049721 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
4,4'-diaminodiphenylmethane |
5.10 | 8074119 |
MESH:D014571 |
Urologic Neoplasms |
|
2,4-dinitrotoluene |
4.43 | 10091137 |
MESH:D014591 |
Uterine Diseases |
|
bisphenol A |
5.14 | 14652134 |
MESH:D020257 |
Ventricular Remodeling |
|
valsartan |
5.82 | 19027736 |